Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?
Yuko Oya, Tetsuya Mitsudomi
Topics & Concepts
MedicinePresentation (obstetrics)Medical physicsData scienceComputer scienceSurgeryChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsLung Cancer Treatments and Mutations